Apolipoprotein E genotyping in a sample of Colombian patients with Alzheimer's disease

Neurosci Lett. 2001 Jun 8;305(2):135-8. doi: 10.1016/s0304-3940(01)01829-8.

Abstract

Apolipoprotein E e4 (APOEe4) allele has been associated with an increased risk for Alzheimer's disease (AD) in diverse populations. Few studies have been carried out in Hispano-Americans and results are inconclusive due to ethnic diversity. This study determined the frequency of APOE alleles in a group of 61 Caucasian-Mestizos patients with probable AD, and 61 age- and sex-matched controls. APOEe4 frequency was 36.8% for patients, and 8.2% for controls (P < 0.0001; OR 7.6). Genotype frequencies differ between the two groups (P < 0.0001). Genotype 3/3 was the most common. Frequency of genotypes 3/4, 4/4 and 2/4 were higher in patients than in the controls. Our results show a highly significant association of APOEe4 with AD, and implies the importance of APOEe4 as a risk factor in this population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4
  • Apolipoproteins E / genetics*
  • Case-Control Studies
  • Cohort Studies
  • Colombia
  • Female
  • Gene Frequency
  • Genotype
  • Hispanic or Latino / genetics
  • Humans
  • Indians, South American / genetics
  • Male
  • Middle Aged
  • Reference Values
  • White People / genetics

Substances

  • Apolipoprotein E4
  • Apolipoproteins E